Bursac N (2012) Colonizing the heart from the epicardial side. Stem Cell Res Ther 3(2):15
Richter M, Kostin S (2015) The failing human heart is characterized by decreased numbers of
telocytes as result of apoptosis and altered extracellular matrix composition. J Cell Mol Med
19(11):2597–2606
Zhao B, Liao Z, Chen S et al (2014) Intramyocardial transplantation of cardiac telocytes
decreases myocardial infarction and improves post-infarcted cardiac function in rats. J Cell
Mol Med 18(5):780–789
Manole CG, Cismaşiu V, Gherghiceanu M et al (2011) Experimental acute myocardial infarc-
tion: telocytes involvement in neo-angiogenesis. J Cell Mol Med 15(11):2284–2296
Bei Y, Zhou Q, Sun Q et al (2016) Telocytes in cardiac regeneration and repair. Semin Cell
Dev Biol 55:14–21
Fu S, Zhu H, Li S et al (2016) Telocytes in cardiac protection. Curr Stem Cell Res Ther
11(5):390–394
Xiao J, Chen P, Qu Y et al (2016) Telocytes in exercise-induced cardiac growth. J Cell Mol
Med 20(5):973–979
Booth A, Magnuson A, Fouts J et al (2016) Adipose tissue: an endocrine organ playing a role
in metabolic regulation. Horm Mol Biol Clin Investig 26(1):25–42
Varga I, Miko M, Oravcová L et al (2015) Ultra-structural morphology of long-term culti-
vated white adipose tissue-derived stem cells. Cell Tissue Bank 16(4):639–647
Oishi Y, Manabe I (2016) Integrated regulation of the cellular metabolism and function of
immune cells in adipose tissue. Clin Exp Pharmacol Physiol 43(3):294–303
Xu Y, Cheng X, Hong K et al (2012) How to interpret epicardial adipose tissue as a cause of
coronary artery disease: a meta-analysis. Coron Artery Dis 23(4):227–233
Iacobellis G, Barbaro G (2008) The double role of epicardial adipose tissue as pro- and anti-
inflammatory organ. Horm Metab Res 40(7):442–445
Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, patho-
physiological and clinical features. Trends Endocrinol Metab 22(11):450–457
Shin SY, Yong HS, Lim HE et al (2011) Total and interatrial epicardial adipose tissues
are independently associated with left atrial remodeling in patients with atrial fibrillation.
J Cardiovasc Electrophysiol 22(6):647–655
Sacks HS, Fain JN (2007) Human epicardial adipose tissue: a review. Am Heart
J 153(6):907–917
Imoto-Tsubakimoto H, Takahashi T, Ueyama T et al (2013) Serglycin is a novel adipo-
cytokine highly expressed in epicardial adipose tissue. Biochem Biophys Res Commun
432(1):105–110
Nishida M, Funahashi T, Shimomura I (2007) Pathophysiological significance of adiponec-
tin. Med Mol Morphol 40(2):55–67
Skurk C, Wittchen F, Suckau L et al (2008) Description of a local cardiac adiponectin system
and its deregulation in dilated cardiomyopathy. Eur Heart J 29(9):1168–1180
Aprahamian TR, Sam F (2011) Adiponectin in cardiovascular inflammation and obesity. Int
J Inflam 2011:376909
Villarreal-Molina MT, Antuna-Puente B (2012) Adiponectin: anti-inflammatory and cardio-
protective effects. Biochimie 94(10):2143–2149
Takahashi T, Saegusa S, Sumino H et al (2005) Adiponectin, T-cadherin and tumour
necrosis factor-alpha in damaged cardiomyocytes from autopsy specimens. J Int Med Res
33(2):236–244
Takano H, Obata JE, Kodama Y et al (2009) Adiponectin is released from the heart in patients
with heart failure. Int J Cardiol 132(2):221–226
Yin WH, Wei J, Huang WP et al (2012) Prognostic value of circulating adipokine levels and
expressions of adipokines in the myocardium of patients with chronic heart failure. Circ
J 76(9):2139–2147
Tamura T, Furukawa Y, Taniguchi R et al (2007) Serum adiponectin level as an independent
predictor of mortality in patients with congestive heart failure. Circ J 71(5):623–630
